(function(){var loadHandler=window['sl_{95E1BEEB-F09F-45AD-952C-441D2D154419}'];loadHandler&&loadHandler(14, '<div id="spr0_128d3bb"><div id="spr1_128d3bb" class="kern"><img id="img4_128d3bb" src="data/img2.png" width="960px" height="540px" alt="" style="left:0px;top:0px;"/><div id="spr3_128d3bb"><img id="img0_128d3bb" src="data/img0.png" width="960" height="540" alt=""/></div></div><div id="spr2_128d3bb" class="kern"><div id="spr4_128d3bb" style="left:62px;top:94.25px;"><div style="width:0px;"><span id="txt0_128d3bb" class="relpos" style="top:-19.962px;">EUS-CDS with Axios stent</span></div></div><div id="spr5_128d3bb" style="left:26.375px;top:122.625px;"><div style="width:0px;"><span id="txt1_128d3bb" class="relpos" style="left:7.2px;top:0.523px;">Methods</span></div><div style="width:0px;"><span id="txt2_128d3bb" class="nokern relpos" style="left:7.2px;top:29.199px;"></span><span id="txt3_128d3bb" class="relpos" style="left:17.117px;top:26.751px;">Study design: Prospective, multicenter, data collection</span></div><div style="width:0px;"><span id="txt4_128d3bb" class="nokern relpos" style="left:7.2px;top:55.599px;"></span><span id="txt5_128d3bb" class="relpos" style="left:17.117px;top:53.151px;">Patients: Unresectable malignant biliary obstruction</span></div><div style="width:0px;"><span id="txt6_128d3bb" class="nokern relpos" style="left:7.2px;top:81.999px;"></span><span id="txt7_128d3bb" class="relpos" style="left:17.117px;top:79.551px;">Institutions: 5 tertiary referral centers.</span></div><div style="width:0px;"><span id="txt8_128d3bb" class="nokern relpos" style="left:7.2px;top:108.399px;"></span><span id="txt9_128d3bb" class="relpos" style="left:17.117px;top:105.951px;">Procedures: EUS-CDS with Hot Axios</span></div><div style="width:0px;"><span id="txt10_128d3bb" class="relpos" style="left:7.2px;top:158.751px;">Results</span></div><div style="width:0px;"><span id="txt11_128d3bb" class="nokern relpos" style="left:7.2px;top:187.599px;"></span><span id="txt12_128d3bb" class="relpos" style="left:17.117px;top:185.151px;">N=19 (mean age, 70.6 years; 12 men)</span></div><div style="width:0px;"><span id="txt13_128d3bb" class="nokern relpos" style="left:7.2px;top:213.999px;"></span><span id="txt14_128d3bb" class="relpos" style="left:17.117px;top:211.551px;">Technical success rate: 100% without any adverse event</span></div><div style="width:0px;"><span id="txt15_128d3bb" class="nokern relpos" style="left:7.2px;top:240.399px;"></span><span id="txt16_128d3bb" class="relpos" style="left:17.117px;top:237.951px;">Jaundice improved in 79% (&lt;7 days) , 95% (Finally)</span></div><div style="width:0px;"><span id="txt17_128d3bb" class="nokern relpos" style="left:7.2px;top:266.799px;"></span><span id="txt18_128d3bb" class="relpos" style="left:17.117px;top:264.351px;">Median follow-up period: 184 days (12-819 days)</span></div><div style="width:0px;"><span id="txt19_128d3bb" class="nokern relpos" style="left:7.2px;top:293.199px;"></span><span id="txt20_128d3bb" class="relpos" style="left:17.117px;top:290.751px;">The overall AE: 36.8% (7/19) mostly with mild severity.</span></div><div style="width:0px;"><span id="txt21_128d3bb" class="nokern relpos" style="left:7.2px;top:319.599px;"></span><span id="txt22_128d3bb" class="relpos" style="left:17.117px;top:317.151px;">Stent obstruction</span></div><div style="width:0px;"><span id="txt23_128d3bb" class="nokern relpos" style="left:38.225px;top:347.278px;"></span><span id="txt24_128d3bb" class="relpos" style="left:48.179px;top:343.366px;">food residue 2, kinking 1, tumor ingrowth 1, spontaneous dislodgement 1</span></div></div><div id="spr6_128d3bb" style="left:185.125px;top:496.375px;"><div style="width:0px;"><span id="txt25_128d3bb" class="relpos" style="left:221.015px;top:4.399px;">Tsuchiya T, Bun Teoh AY, Itoi T, Yamao K, Hara K, Nakai Y, Isayama H, Kitano M.</span></div><div style="width:0px;"><span id="txt26_128d3bb" class="relpos" style="left:463.325px;top:22.399px;">Gastrointest Endosc. 2017 online published</span></div></div><div id="spr7_128d3bb" style="left:672.75px;top:131.625px;"><img id="img1_128d3bb" src="data/img32.png" width="225" height="316" alt="" style="left:0.125px;top:-0.063px;"/></div><div id="spr8_128d3bb" style="left:876.25px;top:-2.25px;"><img id="img2_128d3bb" src="data/img33.png" width="83" height="125" alt="" style="left:0.125px;top:-0.062px;"/></div><div id="spr9_128d3bb" style="left:502.625px;top:201.875px;"><img id="img3_128d3bb" src="data/img34.png" width="170" height="136" alt="" style="left:0.062px;top:0.125px;"/></div></div></div>');})();